Top Markets
Coin of the day
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA
株式のランク #32451
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on... Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
株価
$1.11
最終同期: 2026-08-17
時価総額
$10.06M
変化(1日)
1.38%
変化(1年)
-55.98%
US
取引 Lisata Therapeutics, Inc. (LSTA)

カテゴリー

Lisata Therapeutics, Inc.(LSTA)の株価履歴
終値の最高値: $1.12 (2026-08-01)

終値の最安値: $188.93K (1999-03-01)
Lisata Therapeutics, Inc. の株価履歴(1999 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 52.31%
2025 -28.03%
2024 3.05%
2023 -6.25%
2022 -78.23%
2021 -42.33%
2020 -36.52%
2019 -44.38%
2018 26.19%
2017 2.72%
2016 -70.04%
2015 -68.59%
2014 -44.74%
2013 2.99%
2012 11.54%
2011 -61.50%
2010 -9.12%
2009 147.46%
2008 -61.79%
2007 -75.15%
2006 19.82%
2005 -7.65%
2004 -69.11%
2003 253.51%
2002 -86.70%
2001 -26.92%
2000 -63.97%
1999 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$515.58 32.24%
US
$992.01 50.00%
NL
$111.24 -36.86%
AU
$736.64 6.99%
CH
$1.05K -7.55%
KR